Clinical Trial Update: Efficacy and Safety of High Intensity Focused Ultrasound (HIFU) Device to Treat Secondary Hyperparathyroidism [NA]

View source ↗

Summary

A clinical trial evaluating a High Intensity Focused Ultrasound (HIFU) device to treat secondary hyperparathyroidism has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Hyperparathyroidism
• Parathyroid Hyperplasia

Snippet

Sponsor: Theraclion | Conditions: Secondary Hyperparathyroidism, End Stage Renal Disease | NA | Status: WITHDRAWN